Skip to main content
Log in

Ubretid (distigmine bromide) taken to treat urinary retention prolongs the effect of suxamethonium

  • Letter to the Editor
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Valdrighi JB, Fleming NW, Smith BK, Baker GL, White DA. Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium. Br J Anaesth. 1994;72:237–239.

    Article  PubMed  CAS  Google Scholar 

  2. Crowe S, Collins L. Suxamethonium and donepezil: a cause of prolonged paralysis. Anesthesiology. 2003;98:574–575.

    Article  PubMed  Google Scholar 

  3. Koga M, Miyata H, Tsuno N, Nakayama K, Ushijima S, Tanaka Y, Hiraga Y, Kobayashi N. Relationship between cholinergic symptoms caused by distigmine and the activities of serum AChE and BChE (in Japanese). Nihon Shinkeiseishinyakurigaku Zasshi (Jpn J Neuropsychopharmacol). 1997;17:143–147.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Isono, S., Iizuka, K., Fukami, G. et al. Ubretid (distigmine bromide) taken to treat urinary retention prolongs the effect of suxamethonium. J Anesth 22, 337 (2008). https://doi.org/10.1007/s00540-008-0630-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-008-0630-6

Keywords

Navigation